Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis
Author:
Affiliation:
1. The Third Departments of Tumor Surgery, General Hospital of Ningxia Medical University, Yinchuan City, Ningxia, China
2. Cerebrospinal Fluid Laboratory; General Hospital of Ningxia Medical University, Yinchuan City, Ningxia, China
Publisher
Informa UK Limited
Subject
Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1962685
Reference45 articles.
1. Cancer Statistics, 2021
2. Breast cancer
3. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. X-LDA: An interpretable and knowledge-informed heterogeneous graph learning framework for LncRNA-disease association prediction;Computers in Biology and Medicine;2023-12
2. The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver;International Immunopharmacology;2023-10
3. The Long Non-Coding RNA ANRIL in Cancers;Cancers;2023-08-17
4. CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective;Biochemical Pharmacology;2023-07
5. MicroRNA-122 in human cancers: from mechanistic to clinical perspectives;Cancer Cell International;2023-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3